US-based specialty pharmaceutical firm Par Pharmaceutical has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clonidine hydrochloride (HCl) extended-release (ER) ...
Tags: Par Pharmaceutical, Medicine
TPG and Par Pharmaceutical have announced the completion of Par's purchase by certain TPG affiliates. According to the merger agreement, Par's stockholders are eligible to earn $50.00 in cash, without interest, less any applicable ...